secwatch.observer — SEC 8-K summary
======================================

Issuer:     PULSE BIOSCIENCES, INC. (PLSE)
CIK:        0001625101
Form:       8-K
Filed at:   2025-02-04T23:59:59+00:00
Accession:  0001437749-25-002664
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pulse Biosciences appoints Jon Skinner as CFO effective Feb 3, 2025
-------------------------------------------------------------------

- Jon Skinner appointed CFO effective Feb 3, 2025; previously VP at Copeland and Imperative Care.
- Annual base salary $400,000, target bonus 50% of salary, sign-on bonus up to $56,000.
- Granted option for 300,000 shares at $20.93 (closing on Jan 31, 2025) with four-year vesting.
- Half of options vest time-based over 4 years; half vest based on market cap and revenue milestones.
- Milestones include market caps of $2B to $5B and GAAP product revenues of $8M to $175M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625101/000143774925002664/0001437749-25-002664-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625101/000143774925002664/plse20250131_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-002664

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer